- DiagnaMed Holdings (DMED) will incorporate OpenAI’s technology, ChatGPT, in its BRAIN AGE Artificial Intelligence Product Suite
- DiagnaMed’s Brain Health Digital Platform includes assessment tools, each capturing different aspects of brain health
- DiagnaMed Holdings is an AI-driven digital health company focusing on improving brain health for mental health and neurodegenerative disorders
- DiagnaMed Holdings Corp. (DMED) is unchanged on the day, trading at C$0.03 per share at 10:30 am ET
DiagnaMed Holdings (DMED) will incorporate OpenAI’s technology, ChatGPT, in its BRAIN AGE Artificial Intelligence Product Suite.
The suite already includes a variety of API interfaces to build AI and machine learning functions to enhance the company’s novel Brain Health Digital Platform to assess overall brain health and the presence of cognitive impairment in athletes and those diagnosed with mental health and neurodegenerative conditions.
DiagnaMed’s Brain Health Digital Platform includes several assessment tools generated by self-report or clinician-observed measures, each capturing different aspects of brain health to evaluate overall brain health, output a patient risk score, and provide actionable treatment plans and interventions.
As part of the BRAIN AGE AI Product Suite, the Brain Health Platform will also include unique brain training, games, education, and coaching applications. The company expects to launch the Brain Health Digital Platform as a general clinical tool in May 2023.
“Our Brain Health Digital Platform, which is part of our BRAIN AGE AI product suite, offers licensed professionals a novel brain health assessment tool, patient risk score, and helpful intervention plans and techniques, incorporating OpentAI’s technology, ChatGPT, with the aim to improve brain health and brain age of patients,” said Fabio Chianelli, Chairman of DiagnaMed.
“We expect to launch the Brain Health Digital Platform in the U.S. and Canada in Q2-2023 for use in sports, mental health and neurology clinics that are committed to improving the brain health of over 50 million people with mental health and neurological disorders.”
DiagnaMed Holdings is an AI-driven digital health company focusing on improving brain health for mental health and neurodegenerative disorders. The company is developing its BRAIN AGE AI Product Suite, an electroencephalogram-based (EEG) artificial intelligence solution to detect an individual’s brain age, and the Brain Health Digital Platform for clinical and home use.
Diagnamed Holdings Corp. (DMED) is unchanged on the day, trading at C$0.03 per share at 10:30 am ET.
